Evergreen Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,058
Closed -$47.7K 106
2025
Q3
$47.7K Sell
1,058
-210
-17% -$9.81K 0.02% 113
2025
Q2
$58.7K Hold
1,268
0.02% 109
2025
Q1
$77.3K Hold
1,268
0.04% 102
2024
Q4
$71.7K Hold
1,268
0.03% 106
2024
Q3
$65.6K Hold
1,268
0.03% 109
2024
Q2
$52.7K Sell
1,268
-324
-20% -$14.5K 0.03% 115
2024
Q1
$86.3K Sell
1,592
-100
-6% -$5.09K 0.04% 105
2023
Q4
$86.8K Buy
+1,692
New +$88.8K 0.05% 96

Other funds holding BMY

Evergreen Private Wealth's BMY Position: Q4 2025 in Review

Evergreen Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 1,058 shares — an estimated $47.7K sold.

Evergreen Private Wealth first reported a position in BMY in Q4 2023 and held it in 8 quarters. The position peaked at $86.8K in Q4 2023. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Evergreen Private Wealth reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Evergreen Private Wealth sold 1,058 Bristol-Myers Squibb shares in Q4 2025, an estimated $47.7K.
  • Evergreen Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 8 quarters.
  • Evergreen Private Wealth's Bristol-Myers Squibb position peaked at $86.8K in Q4 2023.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Evergreen Private Wealth's 13F filing for Q4 2025, filed 28 Jan 2026.